Cremers T

References (4)

Title : Therapeutic doses of antidepressants are projected not to inhibit human alpha4beta2 nicotinic acetylcholine receptors - Weber_2013_Neuropharmacol_72_88
Author(s) : Weber ML , Hofland CM , Shaffer CL , Flik G , Cremers T , Hurst RS , Rollema H
Ref : Neuropharmacology , 72 :88 , 2013
Abstract :
PubMedSearch : Weber_2013_Neuropharmacol_72_88
PubMedID: 23639435

Title : Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence - Rollema_2010_Br.J.Pharmacol_160_334
Author(s) : Rollema H , Shrikhande A , Ward KM , Tingley FD, 3rd , Coe JW , O'Neill BT , Tseng E , Wang EQ , Mather RJ , Hurst RS , Williams KE , De Vries M , Cremers T , Bertrand S , Bertrand D
Ref : British Journal of Pharmacology , 160 :334 , 2010
Abstract :
PubMedSearch : Rollema_2010_Br.J.Pharmacol_160_334
PubMedID: 20331614

Title : Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism - Giorgetti_2010_J.Pharmacol.Exp.Ther_333_748
Author(s) : Giorgetti M , Gibbons JA , Bernales S , Alfaro IE , Drieu La Rochelle C , Cremers T , Altar CA , Wronski R , Hutter-Paier B , Protter AA
Ref : Journal of Pharmacology & Experimental Therapeutics , 333 :748 , 2010
Abstract :
PubMedSearch : Giorgetti_2010_J.Pharmacol.Exp.Ther_333_748
PubMedID: 20194526

Title : Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models - Van Dam_2005_Neurochem.Int_46_409
Author(s) : Van Dam D , Marescau B , Engelborghs S , Cremers T , Mulder J , Staufenbiel M , De Deyn PP
Ref : Neurochem Int , 46 :409 , 2005
Abstract :
PubMedSearch : Van Dam_2005_Neurochem.Int_46_409
PubMedID: 15737439